aTyr Pharma, Inc. Working Capital to Net Assets Ratio
aTyr Pharma, Inc. working capital to net assets ratio. aTyr Pharma, Inc. (ATYR) has a Working Capital to Net Assets ratio of 96.7% as of December 2025. Working capital of $65.09 Million (current assets of $80.24 Million minus current liabilities of $15.15 Million) is measured against net assets of $67.29 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check aTyr Pharma, Inc. (ATYR) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of aTyr Pharma, Inc. (2012–2025)
Working capital to net assets ratio of aTyr Pharma, Inc. from 2012 to 2025. This chart shows how aTyr Pharma, Inc.'s Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 96.7%, reflecting working capital of $65.09 Million against net assets of $67.29 Million USD. See ATYR defensive interval ratio to measure how many days the company can operate on defensive assets alone.
aTyr Pharma, Inc. Working Capital to Net Assets Ratio by Year (2012–2025)
aTyr Pharma, Inc. working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for aTyr Pharma, Inc. from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see aTyr Pharma, Inc. assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.7% | $65.09 Million | $67.29 Million | $80.24 Million | $15.15 Million | ▲ +0.8 pp |
| 2024 | 95.9% | $66.99 Million | $69.83 Million | $81.95 Million | $14.97 Million | ▲ +0.2 pp |
| 2023 | 95.7% | $86.58 Million | $90.47 Million | $102.99 Million | $16.42 Million | ▲ +1.7 pp |
| 2022 | 94.0% | $67.01 Million | $71.28 Million | $80.87 Million | $13.86 Million | ▼ -4.6 pp |
| 2021 | 98.6% | $107.56 Million | $109.13 Million | $113.57 Million | $6.01 Million | ▲ +4.3 pp |
| 2020 | 94.2% | $29.67 Million | $31.48 Million | $35.53 Million | $5.86 Million | ▲ +3.9 pp |
| 2019 | 90.4% | $19.00 Million | $21.03 Million | $31.93 Million | $12.92 Million | ▼ -28.4 pp |
| 2018 | 118.8% | $39.97 Million | $33.65 Million | $50.80 Million | $10.83 Million | ▼ -0.4 pp |
| 2017 | 119.2% | $76.59 Million | $64.25 Million | $86.98 Million | $10.39 Million | ▲ +13.7 pp |
| 2016 | 105.5% | $66.24 Million | $62.80 Million | $74.77 Million | $8.53 Million | ▲ +30.9 pp |
| 2015 | 74.6% | $85.80 Million | $115.05 Million | $97.95 Million | $12.15 Million | ▲ +81.6 pp |
| 2014 | -7.0% | $6.40 Million | $-91.01 Million | $16.51 Million | $10.11 Million | ▲ +41.1 pp |
| 2013 | -48.1% | $31.81 Million | $-66.08 Million | $37.02 Million | $5.21 Million | ▲ +28.0 pp |
| 2012 | -76.2% | $960.00K | $-1.26 Million | $4.49 Million | $3.53 Million | — |